Correlation Between FitLife Brands, and Tandem Diabetes

Can any of the company-specific risk be diversified away by investing in both FitLife Brands, and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FitLife Brands, and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FitLife Brands, Common and Tandem Diabetes Care, you can compare the effects of market volatilities on FitLife Brands, and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FitLife Brands, with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of FitLife Brands, and Tandem Diabetes.

Diversification Opportunities for FitLife Brands, and Tandem Diabetes

0.07

Correlation Coefficient

FitLife Brands,  Tandem Diabetes

Significant diversification

The 3 months correlation between FitLife and Tandem is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding FitLife Brands, Common and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and FitLife Brands, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FitLife Brands, Common are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of FitLife Brands, i.e., FitLife Brands, and Tandem Diabetes go up and down completely randomly.

Pair Corralation between FitLife Brands, and Tandem Diabetes

Given the investment horizon of 90 days FitLife Brands, Common is expected to under-perform the Tandem Diabetes. But the stock apears to be less risky and, when comparing its historical volatility, FitLife Brands, Common is 1.62 times less risky than Tandem Diabetes. The stock trades about -0.04 of its potential returns per unit of risk. The Tandem Diabetes Care is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  3,251  in Tandem Diabetes Care on October 3, 2024 and sell it today you would earn a total of  351.00  from holding Tandem Diabetes Care or generate 10.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

FitLife Brands, Common  vs.  Tandem Diabetes Care

FitLife Brands, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FitLife Brands, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, FitLife Brands, is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Tandem Diabetes Care

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tandem Diabetes Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with FitLife Brands, and Tandem Diabetes

The main advantage of trading using opposite FitLife Brands, and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FitLife Brands, position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.

The idea behind FitLife Brands, Common and Tandem Diabetes Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.